SG Americas Securities’s Recursion Pharmaceuticals RXRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$468K	Buy	152,567 +77,343	+103%	+$299K	﹤0.01%	2219
2025 Q4	$308K	Buy	75,224 +60,523	+412%	+$300K	﹤0.01%	2745
2025 Q3	$72K	Sell	14,701 -140,530	-91%	-$738K	﹤0.01%	3142
2025 Q2	$785K	Sell	155,231 -6,837	-4%	-$33.6K	﹤0.01%	1330
2025 Q1	$857K	Buy	162,068 +112,725	+228%	+$822K	﹤0.01%	1302
2024 Q4	$334K	Sell	49,343 -39,982	-45%	-$269K	﹤0.01%	1689
2024 Q3	$589K	Buy	89,325 +63,727	+249%	+$457K	﹤0.01%	1543
2024 Q2	$192K	Buy	+25,598	New	+$223K	﹤0.01%	2184
2024 Q1	–	Sell	-22,186	Closed	-$219K	–	3381
2023 Q4	$219K	Sell	22,186 -16,741	-43%	-$119K	﹤0.01%	2080
2023 Q3	$298K	Buy	38,927 +6,818	+21%	+$68K	﹤0.01%	2079
2023 Q2	$240K	Sell	32,109 -22,901	-42%	-$160K	﹤0.01%	1728
2023 Q1	$367K	Buy	55,010 +26,988	+96%	+$214K	﹤0.01%	1954
2022 Q4	$216K	Buy	28,022 +9,882	+54%	+$96.9K	﹤0.01%	2140
2022 Q3	$193K	Buy	18,140 +6,373	+54%	+$64.5K	﹤0.01%	2357
2022 Q2	$96K	Buy	+11,767	New	+$78.7K	﹤0.01%	3142
2022 Q1	–	Sell	-22,842	Closed	-$391K	–	3363
2021 Q4	$391K	Buy	22,842 +10,576	+86%	+$199K	﹤0.01%	2307
2021 Q3	$282K	Buy	+12,266	New	+$348K	﹤0.01%	2994